NCT04047316 is a clinical trial of Digital dermoscopy in Skin Cancer, sponsored by Barco NV.

Who is sponsoring NCT04047316?

NCT04047316 is sponsored by Barco NV.

What drugs are being tested in NCT04047316?

Interventions in NCT04047316: Digital dermoscopy.

What condition does NCT04047316 study?

NCT04047316 studies Skin Cancer.

Is NCT04047316 still recruiting?

NCT04047316 is currently completed. Last updated 18 June 2020.

Last reviewed 2020-06-18 · How we verify

NCT04047316

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development and Validation of a New Digital Dermatoscope in the United States

Completed Last updated 18 June 2020

What this trial tests

trial testing Digital dermoscopy in Skin Cancer in 60 participants. Completed in 15 April 2020.

Timeline

27 August 2019

Primary endpoint
15 April 2020

15 April 2020

Quick facts

Lead sponsor	Barco NV
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	27 August 2019
Primary completion	15 April 2020
Estimated completion	15 April 2020
Sites	2 locations across United States

Drugs / interventions tested

Digital dermoscopy

Conditions studied

Skin Cancer — all drugs for Skin Cancer →

Sponsor

Barco NV

Who can join

Eligibility, any sex, with Skin Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A completely new type of digital dermatoscope has been developed in order to take a significant step forward in technology for skin cancer imaging. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Skin Cancer

Currently open trials in the same condition.

NCT07288073 — TIL Therapy in cSCC and MCC · Phase 2 · recruiting
NCT06926075 — Early Phase Study of KESONOTIDE™in Participants With Solid Tumours · Phase 1, PHASE2 · recruiting
NCT06932172 — Artificial Intelligent Decision Support for Skin Cancer Diagnostics in Primary Care · NA · recruiting
NCT07510061 — Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient Individuals · NA · recruiting
NCT07200544 — Meloxicam in Mohs Micrographic Surgery · Phase 4 · recruiting

Other Barco NV trials

Trials by the same sponsor.

NCT03497455 — Utility of Digital Dermoscopy in the Skin Cancer Clinic · terminated
NCT03818620 — Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04047316 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Barco NV
Last refreshed: 18 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04047316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing